Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Issa

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Blood Advances|June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized studyPierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDSH Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Cancer Discovery|April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCurtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Blood Neoplasia|June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDSH Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor TherapyH Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Nature Communications|January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomasXin Hu, Marcos R Estecio, Runzhe Chen, et al.
Cell|November 21, 2018
Targeting CDK9 Reactivates Epigenetically Silenced Genes in CancerHanghang Zhang, Somnath Pandey, Meghan Travers, et al.
Cancer Research|January 13, 2025
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in CancerLora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.
Blood Advances|June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized studyPierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDSH Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.
Cancer Discovery|April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCurtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.
Blood Neoplasia|June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDSH Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor TherapyH Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.
Nature Communications|January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomasXin Hu, Marcos R Estecio, Runzhe Chen, et al.
Cell|November 21, 2018
Targeting CDK9 Reactivates Epigenetically Silenced Genes in CancerHanghang Zhang, Somnath Pandey, Meghan Travers, et al.
Cancer Research|January 13, 2025
ZNFX1 Functions as a Master Regulator of Epigenetically Induced Pathogen Mimicry and Inflammasome Signaling in CancerLora Stojanovic, Rachel Abbotts, Kaushelendra Tripathi, et al.
Pageof 21